CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. et al. vs. Bausch Health Ireland Limited et al.

Explore the PTAB proceeding IPR2022-00722 filed by Mylan Pharmaceuticals Inc. et al. on 2022-03-21. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2022-00722

Filing Date

2022-03-21

Accorded Filing Date

2022-03-21

Institution Decision Date

2022-09-14

Last Modified Date

2026-03-31

Proceeding Type

IPR

Termination Date

2026-01-27

Trial Status

Final Written Decision - Appealed

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 10107814
Respondent Patent Number 7041786
Legal Expiration Date
2028-01-30 Active (1.2 yrs remaining)
Patent Term Adjustment (PTA) +2134 Days Awarded
Injunction Viability (35 U.S.C. § 283) Active Threat
Respondent Inventor Kunwar Shailubhai et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

5 Total

Proceeding Status

Final Written Decision - Appealed

Board Decisions & Rulings (5)

Final Written Decision On CAFC Remand 2026-01-27
Final Written Decision: JUDGMENT Final Written Decision on Remand Determining No Challenged Claims Unpatentable 35 U.S.C. §§ 144, 318 Granting Patent Owner’s Motion to Exclude 37 C.F.R. § 42.64(c)
35 U.S.C. Trial Decision
Vacated/Remanded 2025-07-29
Other: Fed Circuit mandate
35 U.S.C. Trial Decision
Final Written Decision 2023-09-08
Final Written Decision: original
35 USC 318
Institution Granted(Joined) 2022-12-14
Institution decision and grant of joinder, IPR2023-00016
35 USC 315, 35 USC 314, 37 CFR 42.122
Institution Granted 2022-09-14
Institution Decision: Granting Institution of Inter Partes Review 35 U.S.C. sec. 314 Granting Petitioners Motion to Amend Real Party in Interest Statement 37 C.F.R. sec. 42.5
35 USC 325, 37 CFR 42.5, 35 USC 314

Address and Attorney/Agent Information

20 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Saul Ewing LLP / Bausch Health - Attn: Patent Docket Clerk
Customer Number 162421
Address 1200 Liberty Ridge Drive, Suite 200, Wayne, PA, 19087-5569, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
32942 Mark Simpson +1 215-972-7880
36317 Kathryn Doyle +1 215-972-7734
36358 Gianna Julian-Arnold +1 410-332-8913
41472 Darius Gambino +1 215-972-7173
52441 Peter Brunovskis +1 202-662-2782
56969 Daniel Kopp +1 202-344-4600
60882 Alireza Behrooz +1 202-295-6687
62074 Brian Landry +1 617-912-0969

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 12 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (12): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2022-10-12
IPR2023-00016

MSN Laboratories Private Ltd. et al. v. Bausch Health Ireland Limited et al.

Asserted Patent
Status: Final Written Decision - Appealed
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

200
107

Petitioner's MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Notice of Appeal NOTICE

2026-03-31 FILING PARTY: PETITIONER
105

Final Written Decision: JUDGMENT Final Written Decision on Remand Determining No Challenged Claims Unpatentable 35 U.S.C. §§ 144, 318 Granting Patent Owner’s Motion to Exclude 37 C.F.R. § 42.64(c) FINAL

2026-01-27 FILING PARTY: BOARD
2077

EX2077 - Deposition Transcript of Blake R. Peterson, Ph.D. Exhibit

2025-12-05 FILING PARTY: PATENT OWNER
104

Patent Owner's Updated Exhibit List NOTICE

2025-12-05 FILING PARTY: PATENT OWNER
103

Patent Owner's Reply Brief OTHER

2025-12-05 FILING PARTY: PATENT OWNER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc